Zenaxis Co., Ltd., a bio-healthcare specialized accelerator (AC) and operator of the [2025 US Bio Investment Attraction Capacity Building Program], announced that it will operate the 'Boston Local Program' to strengthen investment attraction capacity in Boston, USA from September 14th to 20th with five promising bio-healthcare startups in Gyeonggi Province.
The five companies participating in this local program are part of the [2025 US Bio Investment Attraction Capacity Building Program], and were selected as excellent companies through a mock demo day selection evaluation held on August 21st with the participation of domestic and international VCs and bio experts.
The selected companies are ▲Deepson Bio ▲Radaheim ▲Laon Medi ▲Billix ▲Exosystems. Deepson Bio is a bio healthcare company that develops non-invasive therapeutic devices for major brain diseases such as Alzheimer's disease, mild cognitive impairment, and idiopathic normal pressure hydrocephalus. Radahheim is leading the development of new drugs and innovation in precision medicine through an automated mass production platform for organoids that can replace animal testing. Raon Medi is a digital dentistry startup that develops AI-based dental image diagnosis and orthodontic treatment planning solutions, and Billix is pursuing clinical development and technology transfer based on the world's first bilirubin pharmaceutical technology. Exosystems presents a solution to promote neuromuscular health through AI digital biomarkers and customized treatment technology.
Participating companies will expand their global investor networks, verify local market suitability, and seek practical investment opportunities through meetings with various related organizations and multinational pharmaceutical companies, including 'RESI Boston 2025' to be held in Boston in September.
The main program, RESI Boston 2025, will feature Innovator's Pitch Challenge (IPC) presentations, one-on-one partnering meetings, and exhibition booth operations. Furthermore, GenAxis, as a Silver Sponsor, will host a Pre-RESI Demo Day, followed by LSN newsletters and LinkedIn promotions to enhance the global awareness of participating companies. A full attendee list will be provided after the event, enabling follow-up collaboration and networking opportunities.
A GenAxis official said, “This local program, held in Boston, the center of the global bio industry, will be an important stepping stone for domestic bio and healthcare startups to leap into the global market,” adding, “It will be an opportunity to expand practical contact points with investors and enhance global competitiveness.”
- See more related articles
You must be logged in to post a comment.